Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;101:e90

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O’Rourke, M.
Right arrow Articles by Xiong-Jing, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O’Rourke, M.
Right arrow Articles by Xiong-Jing, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Hypertension - basic studies
Right arrow Coronary circulation
Right arrow Other Vascular biology

(Circulation. 2000;101:e90.)
© 2000 American Heart Association, Inc.


Circulation Electronic Pages

Sildenafil/Nitrate Interaction

Michael O’Rourke, MD, DSc; Jiang Xiong-Jing

Medical Professorial Unit, University of New South Wales, St Vincent’s Hospital, Sydney, Australia


*    Introduction
 
To the Editor:

The ACC/AHA consensus document on sildenafil (Viagra)1 takes a very cautious approach to interaction between organic nitrates and sildenafil, suggesting that neither should be used within 24 hours of the other in any dose and by any route of administration. While justifiable on the basis of current information (Pfizer studies 148/230 and 148/231, which show approximate doubling of maximal blood pressure reduction by nitrate after sildenafil), this approach could result in the withholding of nitrates for conditions in which their own effects may be lifesaving and when administration may be safe in an appropriately low dose.

The document refers to nitrate action and interaction with sildenafil only on the basis of change in arterial pressure (and for a very small group, in pulmonary pressure and cardiac output). The powerful beneficial effects of organic nitrate on conduit arteries, wave reflection, and aortic impedance2 3 are not mentioned in the report. Effects of nitrates on arterial wave reflection cause characteristic changes in the radial (as well as the aortic) pressure waveform2 3 and were illustrated in Murrell’s initial description of nitroglycerine as an antianginal agent in 1879.4 These effects can be quantified as a reduction in augmentation of the ascending aortic systolic pressure, as generated from the radial artery pressure pulse waveform by applanation tonometry.2 3

Using this method, we have been able to show in a limited study that sildenafil 50 mg approximately doubles the effect of a small dose of glyceryl trinitrate administered by dermal patch, that this effect begins . . . [Full Text of this Article]